Latest News

Filters

Filter by tags: United States Europe CANDU reactor Clear all tag filters

14 news articles found


The deployment of four AP1000 units in Ontario could have an impact of more than CAD28.7 billion (USD21.2 billion) on Canada's GDP during the manufacturing, engineering and construction phase alone, an independent study has found.

Date: Friday, 01 March 2024
Original article: world-nuclear-news.org/Articles/Canadian-AP1000-deployment-could-bring-billions-in

Canada and Romania have signed a CAD3bn ($2.2bn) export development deal to support construction of two new units at the Cernavoda NPP. Canadian Energy Minister Jonathan Wilkinson said the financing offer for Romania’s national nuclear operator, Nuclearelectrica, to buy supplies or services from Canadian companies.

Date: Friday, 22 September 2023
Original article: neimagazine.com/news/newscanada-agrees-funding-for-cernavoda-expansion-11163290

The Canadian Minister of Energy and Natural Resources Jonathan Wilkinson has announced CAD3 billion (USD2.2 billion) of export financing to Nuclearelectrica to support the building of two CANDU-6 reactors at the Cernavoda nuclear power plant in Romania.

Date: Thursday, 21 September 2023
Original article: world-nuclear-news.org/Articles/Canada-offers-CAD3-billion-finance-for-new-nuclear

Romanian nuclear utility SN Nuclearelectrica (SNN) and the Polytechnic University of Bucharest (UPB) have launched a NuScale Power Energy Exploration Centre (E2 Centre) at the University’s Faculty of Energy Engineering. It includes a control room simulator for NuScale’s VOYGR small modular reactor (SMR) power plant. It is the first E2 Centre to be established outside the USA. The first E2 Centre was opened at Oregon State University in 2020.

Date: Thursday, 18 May 2023
Original article: neimagazine.com/news/newsus-supports-opening-of-nuscales-energy-exploration-centre-in-romania-10858705

Advances in emerging field of ‘theranostics’ are a game-changer Millions of patients around the globe rely on the regular and timely production of diagnostic and therapeutic isotopes produced in research reactors and accelerator facilities. Image courtesy IAEA. Advances in medical isotope diagnostics and therapy are holding promise for cancer patients, despite challenges facing the nuclear medical field in recent years related to radionuclide production and supply, rising costs, and stricter regulation.

Medical isotopes are radioactive substances used in various diagnostic and therapeutic procedures to treat various types of cancers and other conditions. They are essential for modern medicine, allowing physicians to visualise and target specific organs, tissues and cells in a patient’s body.

Over more than a decade, personalised medicine using nuclear techniques has been gaining pace, allowing doctors to tailor therapies and treatments to the specific needs and physiology of a patient, and to avoid harm to healthy organs or tissues.

According to Sven Van den Berghe, chief executive of Belgium-based isotope producer PanTera, one technique that has seen significant advances is known as theranostics – the term used to describe the combination of using one radioactive drug to diagnose and a second to deliver therapy to treat the main tumour and any metastatic tumours.

Date: Friday, 14 April 2023
Original article: nucnet.org/news/sector-aims-to-tackle-isotope-supply-problems-as-excitement-grows-over-targeted-therapies-4-4-2023

Romainia’s nuclear utility SN Nuclearelectrica SA (SNN) says it put into operation its Feldioara Branch during January-March as part of its strategy for development of an integrated nuclear fuel cycle.

Date: Wednesday, 12 April 2023
Original article: neimagazine.com/news/newsromania-launches-integrated-fuel-cycle-as-kazakhstan-delivers-uranium-10747766

In a wide ranging interview for the World Nuclear News podcast, Cameco CEO Tim Gitzel explained: Why the time was right for the Westinghouse deal How Russia's war with Ukraine has led to 'bifurcation' of the nuclear sector Explained Cameco's long-term strategy Looks ahead at the impact of new technologies, including SMRs How nuclear will need to play a key role in getting to net-zero

Date: Wednesday, 09 November 2022
Original article: world-nuclear-news.org/Articles/In-Quotes-Cameco-s-Tim-Gitzel-WNN-podcast-on-nucle

GE Hitachi to provide technology for project The first unit could be ready for operation at Darlington in 2028. Courtesy GEH/OPG. Canadian utility Ontario Power Generation (OPG) has submitted a construction licence application to the national nuclear regulator which could pave the way to the deployment of a small modular reactor (SMR) at the site of the Darlington nuclear power station.

OPG said in a statement the application consists of several packages which will be consecutively provided to the Canadian Nuclear Safety Commission (CNSC) over the next six months.

The company said the application has been jointly prepared in partnership with GE Hitachi Nuclear Energy (GEH), which has proposed its BWRX-300 SMR for deployment at Darlington.

Date: Thursday, 03 November 2022
Original article: nucnet.org/news/opg-applies-for-licence-to-build-first-smr-at-darlington-site-11-3-2022

Cameco Corporation and Brookfield Renewable Partners, together with its institutional partners (the consortium), are forming a strategic partnership to acquire Westinghouse Electric Company. Brookfield Renewable, with its institutional partners, will own a 51% interest in Westinghouse and Cameco will own 49%.

Date: Friday, 14 October 2022
Original article: neimagazine.com/news/newscameco-and-brookfield-renewable-to-acquire-westinghouse-10084610

With soaring energy prices and a renewed need for energy security, Professor Radek Skoda from the Czech Technical University puts the case for an innovative nuclear-fuelled district heating system.

Date: Wednesday, 29 June 2022
Original article: world-nuclear-news.org/Articles/Viewpoint-Nuclear-and-the-district-heating-indust